A business in context

ACBM research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-02 · 0001640334-26-001447 · Items 5.02

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001640334-26-001345

  3. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001640334-26-000824

  4. 10-K · Annual report

    Report date 2025-12-31 · 0001640334-26-000241

  5. 8-K · Current report

    Report date 2026-01-04 · 0001640334-26-000053 · Items 4.01,9.01

  6. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001640334-25-001999

  7. 8-K · Current report

    Report date 2025-08-14 · 0001640334-25-001486 · Items 5.02

  8. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001640334-25-001347

  9. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001640334-25-001302

  10. 10-K · Annual report

    Report date 2024-12-31 · 0001640334-25-001300

  11. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001640334-25-001281

  12. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001640334-25-001279

  13. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001640334-25-001257

  14. 10-K · Annual report

    Report date 2023-12-31 · 0001640334-25-001245

  15. 10-Q · Quarterly report

    Report date 2023-09-30 · 0001640334-25-001169

  16. 8-K · Current report

    Report date 2025-06-30 · 0001640334-25-001097 · Items 4.01,9.01

  17. 10-Q · Quarterly report

    Report date 2023-06-30 · 0001640334-23-001563

  18. 10-Q · Quarterly report

    Report date 2023-03-31 · 0001640334-23-001422

  19. 10-K · Annual report

    Report date 2022-12-31 · 0001640334-23-001347

  20. 10-Q · Quarterly report

    Report date 2022-09-30 · 0001640334-22-002503

  21. 10-Q · Quarterly report

    Report date 2022-06-30 · 0001640334-22-001752

  22. 10-Q · Quarterly report

    Report date 2022-03-31 · 0001640334-22-001037

  23. 10-K · Annual report

    Report date 2021-12-31 · 0001640334-22-000809

  24. 10-Q · Quarterly report

    Report date 2021-09-30 · 0001640334-21-002942

  25. 10-Q · Quarterly report

    Report date 2021-06-30 · 0001640334-21-002018

  26. 10-Q · Quarterly report

    Report date 2021-03-31 · 0001640334-21-001236

  27. 10-K · Annual report

    Report date 2020-12-31 · 0001640334-21-000767

  28. SC 13D · Ownership disclosure

    0001640334-21-000454

  29. 10-Q · Quarterly report

    Report date 2020-09-30 · 0001640334-20-002867

  30. 10-Q · Quarterly report

    Report date 2020-06-30 · 0001640334-20-002198

  31. 8-K · Current report

    Report date 2020-08-07 · 0001640334-20-002068 · Items 5.02,5.07,9.01

  32. 10-Q · Quarterly report

    Report date 2020-03-31 · 0001640334-20-001279

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001622996ACRO BIOMEDICAL CO., LTD.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • KILLER WAVES HAWAII, INC · former SEC name · 2014-10-23 to 2017-01-30

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0
2023-12-31$0$0
2022-12-31$658.5K$758.0K
2021-12-31$1.20M$1.49M
2020-12-31$688.0K$895.6K
2019-12-31$193.5K$255.1K
2018-09-30$8.01M$10.81M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗